Literature DB >> 14715362

Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation.

John Fanikos1, Kanella Tsilimingras, Nils Kucher, Allison B Rosen, Melissa D Hieblinger, Samuel Z Goldhaber.   

Abstract

We compared the efficacy, safety, and impact on postoperative hospital length of stay and inpatient hospital costs of low-molecular-weight heparin with that of unfractionated heparin as a "bridge" to achieving therapeutic levels of anticoagulation with warfarin in patients with newly implanted prosthetic heart valves. The patients who received low-molecular-weight heparin had a shorter length of stay and decreased postoperative costs compared with the control subjects receiving unfractionated heparin.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14715362     DOI： 10.1016/j.amjcard.2003.09.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  10 in total

1.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  [Avoiding emergency situations under anticoagulant therapy with vitamin K antagonists].

Authors:  C E Dempfle; M Borggrefe
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

Review 4.  Anticoagulation for mechanical heart valves in patients with and without atrial fibrillation.

Authors:  Usman Baber; Sarina van der Zee; Valentin Fuster
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

5.  Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves.

Authors:  Jacqueline M Schulman; Ammar Majeed; Eva Mattsson; Sam Schulman; Margareta Holmström; Anna Ågren
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

6.  Utility of a dedicated pediatric cardiac anticoagulation program: the Boston Children's Hospital experience.

Authors:  Jenna M Murray; Amy Hellinger; Roger Dionne; Loren Brown; Rosemary Galvin; Suzanne Griggs; Karen Mittler; Kathy Harney; Shannon Manzi; Christina VanderPluym; Annette Baker; Patricia O'Brien; Cheryl O'Connell; Christopher S Almond
Journal:  Pediatr Cardiol       Date:  2015-01-09       Impact factor: 1.655

7.  Low molecular weight heparin in surgical valve procedures: When and how much for an optimal prophylaxis?

Authors:  Katarzyna Czerwińska-Jelonkiewicz; Marek Cisowski; Andrzej Bochenek; Piotr Buszman; Krzysztof Milewski; Piotr Kunik; Magdalena Mularska; Krzysztof Kocot; Piotr Politowski; Jakub Brączkowski; Agata Trznadel; Michael S Aboodi; Paweł Buszman
Journal:  Cardiol J       Date:  2018-11-28       Impact factor: 2.737

8.  Benefits may not outweigh risks of low molecular weight heparin (LMWH) in early postoperative thromboprophylaxis following minimally invasive cardiac surgery: a propensity score-matched analysis.

Authors:  Wei Li; Pei Wang; Shiguan Le; Wang Xi; Jing Wang; Liang Yin; Qing Wang; Yufeng Zhang; Zhinong Wang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

9.  A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin.

Authors:  Ende Tao; Yun Long Luo; Zhe Tao; Li Wan
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

10.  Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized Trial.

Authors:  Sarah Sabry; Lamia Mohamed El Wakeel; Ayman Saleh; Marwa Adel Ahmed
Journal:  Clin Drug Investig       Date:  2022-03-10       Impact factor: 2.859
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.